The arrival of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide and tirzepatide marks an important moment […]
Updated Date: Tue, 09 Sep 2025 00:00:00 EDT
Updated Date: Tue, 09 Sep 2025 00:00:00 EDT
Data from trials highlight long-term disease control and quality of life improvements
First patient dosed in study of novel EP4 antagonist for advanced solid tumours
Updated Date: Tue, 09 Sep 2025 00:00:00 EDT
People taking semaglutide report far fewer obsessive thoughts about food, with cravings dropping sharply and mental health improving. […]
Updated Date: Tue, 09 Sep 2025 00:00:00 EDT
Updated Date: Tue, 09 Sep 2025 00:00:00 EDT
